Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2680-0.0070 (-2.55%)
At close: 04:00PM EST
0.2782 +0.01 (+3.81%)
After hours: 07:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.2750
Bid0.2680 x 1200
Ask0.2698 x 1200
Day's Range0.2680 - 0.2900
52 Week Range0.1750 - 15.2000
Avg. Volume912,005
Market Cap10.885M
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

    FDA Agrees to Extended Milestones for Long-Term Twirla® Safety Study New Publication Supports Eventual Pursuit of AG200-15 Extended Regimen Development Program PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today provided an update on the Twirla® post-marketing studies and status of its ongoing evaluation of the Company’s pipeline. Twirla Post-Marketing Studies As part of Twirla’s approval, the United States Food and Drug

  • GlobeNewswire

    Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock

    PRINCETON, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.0001 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on February 6, 2023. The shares of Series C Preferred Stock will be distributed to such recipients at 5:0